Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$73,471 | -$50,545 | -$21,162 | -$11,294 |
| Dep. & Amort. | $157 | $120 | $67 | $32 |
| Deferred Tax | $3 | $5 | $0 | $0 |
| Stock-Based Comp. | $4,700 | $2,112 | $413 | $111 |
| Change in WC | $3,165 | $1,449 | $2,432 | $88 |
| Other Non-Cash | $3,753 | $5,775 | $568 | $1,084 |
| Operating Cash Flow | -$61,693 | -$41,084 | -$17,682 | -$9,979 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$39 | -$274 | -$238 | -$88 |
| Net Acquisitions | $0 | $8 | -$6,821 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $8 | $0 | $0 |
| Investing Cash Flow | -$39 | -$266 | -$7,059 | -$88 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $29,866 | $3,906 | $0 | -$892 |
| Stock Issued | $6,094 | $66,566 | $831 | $185 |
| Stock Repurch. | $0 | $0 | $0 | -$3,240 |
| Dividends Paid | $0 | $0 | $0 | -$45,392 |
| Other Fin. Act. | $0 | $36,306 | $28,012 | $18,567 |
| Financing Cash Flow | $35,960 | $106,778 | $28,842 | $14,620 |
| Forex Effect | -$169 | -$52 | $28 | $0 |
| Net Chg. in Cash | -$25,941 | $65,376 | $4,129 | $4,553 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $74,648 | $9,091 | $4,962 | $409 |
| End Cash | $48,707 | $74,467 | $9,091 | $4,962 |
| Free Cash Flow | -$61,732 | -$41,358 | -$17,920 | -$10,067 |